Asker Healthcare
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equip… Read more
Asker Healthcare (ASKER) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.068x
Based on the latest financial reports, Asker Healthcare (ASKER) has a cash flow conversion efficiency ratio of 0.068x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr440.00 Million) by net assets (Skr6.51 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Asker Healthcare - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Asker Healthcare's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Asker Healthcare Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Asker Healthcare ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chemring Group PLC
PINK:CMGMF
|
0.134x |
|
Amprius Technologies Inc.
NYSE:AMPX
|
-0.090x |
|
Fabege AB
ST:FABG
|
0.023x |
|
Apeloa Pharmaceutical Co Ltd
SHE:000739
|
0.056x |
|
Wondershare Technology Co Ltd Class A
SHE:300624
|
0.032x |
|
Up Fintech Holding Ltd
NASDAQ:TIGR
|
0.825x |
|
Better Life Commercial Chain Share Co Ltd
SHE:002251
|
0.006x |
|
Electric Connector Technology Co Ltd
SHE:300679
|
0.050x |
Annual Cash Flow Conversion Efficiency for Asker Healthcare (2021–2024)
The table below shows the annual cash flow conversion efficiency of Asker Healthcare from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr3.50 Billion | Skr1.23 Billion | 0.350x | +1.28% |
| 2023-12-31 | Skr3.04 Billion | Skr1.05 Billion | 0.346x | -1.07% |
| 2022-12-31 | Skr2.79 Billion | Skr976.00 Million | 0.350x | +66.61% |
| 2021-12-31 | Skr1.82 Billion | Skr382.00 Million | 0.210x | -- |